Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 12 | 2019 | 311 | 1.680 |
Why?
|
| Antigens, Bacterial | 3 | 2013 | 1155 | 0.770 |
Why?
|
| Antigens, CD1 | 6 | 2009 | 439 | 0.670 |
Why?
|
| Antigens, CD1d | 10 | 2019 | 217 | 0.630 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2019 | 801 | 0.540 |
Why?
|
| Galactosylceramides | 7 | 2019 | 92 | 0.500 |
Why?
|
| Autoantigens | 4 | 2011 | 877 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2019 | 1811 | 0.400 |
Why?
|
| Antigen Presentation | 6 | 2019 | 1254 | 0.340 |
Why?
|
| Lipids | 4 | 2009 | 3336 | 0.330 |
Why?
|
| Phospholipids | 1 | 2013 | 789 | 0.320 |
Why?
|
| Lymphocyte Activation | 9 | 2013 | 5498 | 0.300 |
Why?
|
| Bacterial Infections | 2 | 2011 | 1402 | 0.240 |
Why?
|
| Phosphatidylglycerols | 2 | 2015 | 34 | 0.240 |
Why?
|
| Cytokines | 6 | 2011 | 7345 | 0.220 |
Why?
|
| Burkholderia cepacia | 1 | 2022 | 22 | 0.210 |
Why?
|
| Burkholderia cepacia complex | 1 | 2022 | 24 | 0.210 |
Why?
|
| Burkholderia Infections | 1 | 2022 | 41 | 0.210 |
Why?
|
| Killer Cells, Natural | 4 | 2009 | 2204 | 0.200 |
Why?
|
| Salmonella Infections | 1 | 2003 | 171 | 0.200 |
Why?
|
| Cryptococcosis | 1 | 2022 | 103 | 0.200 |
Why?
|
| Cryptococcus neoformans | 1 | 2022 | 121 | 0.200 |
Why?
|
| Antigen-Presenting Cells | 5 | 2013 | 967 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 1434 | 0.170 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2020 | 165 | 0.160 |
Why?
|
| Nasopharynx | 1 | 2020 | 394 | 0.150 |
Why?
|
| Hybridomas | 3 | 2015 | 442 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 817 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 1006 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2019 | 445 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 857 | 0.120 |
Why?
|
| Interleukin-12 | 2 | 2011 | 584 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1522 | 0.120 |
Why?
|
| Membrane Lipids | 1 | 2015 | 251 | 0.120 |
Why?
|
| Listeria monocytogenes | 1 | 2015 | 249 | 0.110 |
Why?
|
| Cross Infection | 1 | 2022 | 1434 | 0.110 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2013 | 36 | 0.110 |
Why?
|
| Corynebacterium glutamicum | 1 | 2013 | 11 | 0.110 |
Why?
|
| Antigens | 3 | 2015 | 1447 | 0.110 |
Why?
|
| Interferon-gamma | 5 | 2011 | 3160 | 0.110 |
Why?
|
| Cardiolipins | 1 | 2013 | 81 | 0.110 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2006 | 3076 | 0.100 |
Why?
|
| Sphingomonas | 1 | 2011 | 6 | 0.100 |
Why?
|
| Mice | 18 | 2019 | 81216 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 9 | 2013 | 22025 | 0.100 |
Why?
|
| STAT4 Transcription Factor | 1 | 2011 | 93 | 0.100 |
Why?
|
| Cell Line | 5 | 2015 | 15626 | 0.100 |
Why?
|
| Glycosphingolipids | 1 | 2011 | 75 | 0.100 |
Why?
|
| T-Lymphocytes | 4 | 2006 | 10183 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1455 | 0.090 |
Why?
|
| Mice, Knockout | 8 | 2019 | 14396 | 0.090 |
Why?
|
| Immunity, Innate | 3 | 2013 | 3046 | 0.090 |
Why?
|
| beta-Glucans | 1 | 2011 | 121 | 0.090 |
Why?
|
| Aspergillus fumigatus | 1 | 2011 | 156 | 0.090 |
Why?
|
| Animals | 22 | 2019 | 167940 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 267 | 0.090 |
Why?
|
| Thymus Gland | 2 | 2012 | 1246 | 0.090 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2009 | 18 | 0.090 |
Why?
|
| Aspergillosis | 1 | 2011 | 243 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2013 | 18968 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 590 | 0.080 |
Why?
|
| Dendritic Cells | 4 | 2009 | 2730 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2019 | 2536 | 0.080 |
Why?
|
| Cell Wall | 1 | 2011 | 425 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 581 | 0.080 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 1979 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 4355 | 0.080 |
Why?
|
| GATA3 Transcription Factor | 1 | 2006 | 152 | 0.070 |
Why?
|
| Citrobacter rodentium | 1 | 2006 | 64 | 0.060 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 732 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 428 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 9531 | 0.060 |
Why?
|
| Ligands | 1 | 2011 | 3277 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2019 | 5873 | 0.060 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2006 | 192 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2008 | 1400 | 0.060 |
Why?
|
| Immunoglobulin M | 2 | 2023 | 1529 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9989 | 0.050 |
Why?
|
| Candida | 1 | 2022 | 173 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2013 | 1905 | 0.050 |
Why?
|
| Drug Contamination | 1 | 2022 | 152 | 0.050 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 344 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2022 | 508 | 0.050 |
Why?
|
| Autoimmunity | 2 | 2011 | 1370 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2011 | 8314 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 1437 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1999 | 98 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 978 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3822 | 0.040 |
Why?
|
| Glycolipids | 1 | 2019 | 204 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1999 | 283 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 283 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 302 | 0.040 |
Why?
|
| Spleen | 3 | 2009 | 2298 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 607 | 0.040 |
Why?
|
| Protein Transport | 1 | 2004 | 1966 | 0.040 |
Why?
|
| Macrophages | 1 | 2013 | 5745 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 461 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2019 | 3800 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1600 | 0.030 |
Why?
|
| Humans | 19 | 2023 | 760261 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1999 | 654 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 13456 | 0.030 |
Why?
|
| Water | 1 | 2022 | 1402 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1833 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 2214 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5429 | 0.030 |
Why?
|
| Transfection | 1 | 2003 | 5782 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4546 | 0.030 |
Why?
|
| Chemokines | 1 | 1999 | 962 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4739 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 3023 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2299 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1455 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 1295 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11480 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2020 | 1928 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1759 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 1618 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2012 | 32 | 0.030 |
Why?
|
| Th2 Cells | 2 | 2009 | 1048 | 0.030 |
Why?
|
| Dyspnea | 1 | 2020 | 1352 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3145 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3323 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2012 | 419 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1799 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2011 | 23363 | 0.020 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2009 | 19 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 446 | 0.020 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2009 | 71 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 747 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2623 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4189 | 0.020 |
Why?
|
| Glycosides | 1 | 2009 | 112 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8551 | 0.020 |
Why?
|
| Haptens | 1 | 2008 | 163 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4717 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 277 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3061 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 724 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14656 | 0.020 |
Why?
|
| Mitochondria | 1 | 2000 | 3598 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 614 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1765 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13629 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1354 | 0.020 |
Why?
|
| Cell Communication | 1 | 2013 | 1642 | 0.020 |
Why?
|
| Proteins | 1 | 2000 | 6030 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12968 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 2030 | 0.010 |
Why?
|
| Apoptosis | 1 | 2000 | 9497 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1388 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2006 | 522 | 0.010 |
Why?
|
| Drug Design | 1 | 2009 | 1062 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2012 | 2525 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 825 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2005 | 491 | 0.010 |
Why?
|
| Endosomes | 1 | 2005 | 519 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6226 | 0.010 |
Why?
|
| Female | 3 | 2022 | 391011 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1663 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3804 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8621 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2009 | 1805 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2000 | 251 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1697 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1999 | 128 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 1470 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4416 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 258 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1999 | 214 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 4554 | 0.010 |
Why?
|
| Ribosomal Proteins | 1 | 2000 | 359 | 0.010 |
Why?
|
| Colon | 1 | 2006 | 1788 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1168 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 899 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 1902 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1900 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5796 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 220175 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 2178 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1250 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 1955 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2000 | 857 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2000 | 1135 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 4172 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 22066 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1667 | 0.010 |
Why?
|
| Male | 2 | 2020 | 359413 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10434 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16905 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3735 | 0.010 |
Why?
|
| Sepsis | 1 | 2006 | 2594 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2000 | 1892 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 1444 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 6067 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 2895 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 2702 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 4357 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17628 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7592 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2000 | 12762 | 0.000 |
Why?
|
| Mutation | 1 | 2000 | 29950 | 0.000 |
Why?
|
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_